Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gee

Showing results (361-370 of 383) with videos related to

Pageof 39
Sort By:
Breast Cancer Research and Treatment|January 31, 2012
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II studyIrene Kuter, Julia M W Gee, Roberto Hegg, et al.
Journal of Medicinal Chemistry|October 9, 2013
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptorsDerk J Hogenkamp, Thomas A Ford-Hutchinson, Wen-Yen Li, et al.
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptorD J Hogenkamp, S H Tahir, J E Hawkinson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2017
Targeting Elastase for Molecular Imaging of Early Atherosclerotic LesionsAlmut Glinzer, Xiaopeng Ma, Jaya Prakash, et al.
Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptorR B Carter, P L Wood, S Wieland, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Pageof 39

Showing results (361-370 of 383) with videos related to

Sort By:
Pageof 39
Breast Cancer Research and Treatment|January 31, 2012
Dose-dependent change in biomarkers during neoadjuvant endocrine therapy with fulvestrant: results from NEWEST, a randomized Phase II studyIrene Kuter, Julia M W Gee, Roberto Hegg, et al.
Journal of Medicinal Chemistry|October 9, 2013
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of α7 nicotinic acetylcholine receptorsDerk J Hogenkamp, Thomas A Ford-Hutchinson, Wen-Yen Li, et al.
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptorD J Hogenkamp, S H Tahir, J E Hawkinson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2017
Targeting Elastase for Molecular Imaging of Early Atherosclerotic LesionsAlmut Glinzer, Xiaopeng Ma, Jaya Prakash, et al.
Breast Cancer Research and Treatment|February 25, 2009
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHany Onsy Habashy, Desmond G Powe, Cindy M Staka, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptorR B Carter, P L Wood, S Wieland, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
Cancer Research|December 17, 2008
Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survivalJennifer H Law, Golareh Habibi, Kaiji Hu, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
Pageof 39